+61 2-8964 9600 info@lucidhealthcon.com
  • Twitter
  • Linkedin
  • Twitter
  • Linkedin
Lucid Health Consulting | Experience Matters
  • HOME
  • ABOUT
  • SERVICES
    • Market Access and Pricing Strategy
    • Reimbursement Submissions
    • Regulatory Affairs, Quality & Advocacy
    • Economic Modelling & Evaluations
    • Statistical Analyses, Research & Market Intelligence
    • Product Sponsorship and Commercialisation
  • TEAM
  • NEWS
  • PUBLICATIONS
  • VIDEOS
  • RESOURCES
    • PBS Price Calculator
    • Posters
  • CONTACT
Select Page
ISPOR VOS Research RoundUp | November – December 2020.

ISPOR VOS Research RoundUp | November – December 2020.

by George Papadopoulos | Dec 21, 2020 | ISPOR Values & Outcomes SPOTLIGHT

Our Director at Lucid Health Consulting, George Papadopoulos, authored the ISPOR, Research RoundUp in the November-December 2020 Edition of the Value & Outcomes Spotlight. The articles in this session of Research Roundup look at precision medicine. Precision...
Submission to the Consultation on the Medical Services Advisory Committee (MSAC)

Submission to the Consultation on the Medical Services Advisory Committee (MSAC)

by George Papadopoulos | Dec 2, 2020 | Submissions

Submission to the Consultation on the Medical Services Advisory Committee (MSAC) Revised Draft Guidelines Submitted on 2020-10-12   The Medicines Service Advisory Committee (MSAC) appraises medical services, health technologies and/or programs proposed for public...
Lucid Health Consulting enters strategic agreement with MAOSS – for Australian Market Access Data

Lucid Health Consulting enters strategic agreement with MAOSS – for Australian Market Access Data

by George Papadopoulos | Nov 4, 2020 | Lucid Health Consulting News

Lucid Health Consulting is pleased to announce a strategic partnership agreement with MAOSS effective from 1 October 2020.             MAOSS is a unique market access platform, providing a one stop shop for Australian reimbursement data needs. MAOSS has been...
ISPOR VOS Research RoundUp | September – October 2020.

ISPOR VOS Research RoundUp | September – October 2020.

by George Papadopoulos | Oct 27, 2020 | ISPOR Values & Outcomes SPOTLIGHT

Our Director, George Papadopoulos, authored the ISPOR, Research Roundup in the September-October 2020 Edition of the Value & Outcomes Spotlight. The articles featured in this issue’s Research Round-Up look at the current state of real-world evidence (RWE)....
6th Annual Drugs & Devices Australia Webinar, 2020 – Reimbursement Update.

6th Annual Drugs & Devices Australia Webinar, 2020 – Reimbursement Update.

by George Papadopoulos | Oct 21, 2020 | Webinars

Free Webinar: 6th Annual Drugs & Devices Australia – Reimbursement Update.   Please join us for this free webinar, hosted by Sarah Griffin, Director of MedTechnique Consulting and George Papadopoulos Partner & Director of Lucid Health Consulting as they...
Should discount rates be selectively applied in health economic evaluations?

Should discount rates be selectively applied in health economic evaluations?

by George Papadopoulos | Sep 7, 2020 | Discount rates and Economic Evaluations

Authors: Hemant Rathi1 and George Papadopoulos2,3 Skyward Analytics Pte. Ltd., Singapore Lucid Heath Consulting Pty. Ltd., Australia University of New South Wales, School of Medicine, Australia Disclaimer: All opinions expressed in the article are personal  ...
ISPOR VOS Research RoundUp | July-August 2020.

ISPOR VOS Research RoundUp | July-August 2020.

by George Papadopoulos | Sep 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT

Our Director, George Papadopoulos, authored the ISPOR  Research Roundup in the July-August 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies the interface between experimental and behavioural economics and health economics by identifying...
ISPOR VOS Research RoundUp | May- June 2020.

ISPOR VOS Research RoundUp | May- June 2020.

by George Papadopoulos | Jul 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT

Our Director, George Papadopoulos, authored the ISPOR Research Roundup in the May-June 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies recent research publications that highlight innovative pricing models for pharmaceuticals and/or...
Next Entries »

Recent Posts

  • Lucid Health Consulting Medtech Reimbursement workshop at AusMedtech 2025!
  • Lucid Health Consulting – Wrapping Up 2024 and Looking Ahead to 2025
  • Free Webinar: 10th Annual Drugs & Devices Australia Webinar – 2024

Recent Comments

  • admin on Should discount rates be selectively applied in health economic evaluations?
  • Tim Hortons Buffalo on Should discount rates be selectively applied in health economic evaluations?

Archives

  • April 2025
  • December 2024
  • October 2024
  • June 2024
  • May 2024
  • March 2024
  • February 2024
  • November 2023
  • September 2023
  • July 2023
  • March 2023
  • November 2022
  • October 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • October 2021
  • August 2021
  • June 2021
  • April 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • Twitter
  • Linkedin
Created by Spindrift Marketing| © Lucid Health Consulting 2024
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}